{"title":"Bone Resorption Inhibitors","description":"Bone resorption inhibitors are medications used to prevent or slow down the resorption (breakdown) of bones. This process is generally mediated by cells called osteoclasts. By inhibiting these cells, bone resorption inhibitors help maintain or increase bone density, thereby reducing the risk of fractures and other complications associated with low bone density.","products":[{"product_id":"zoledronic-acid-injection-4-mg-5-ml-0-8-mg-ml-single-dose-viial-5-ml-by-avet-pharmaceuticals-rx","title":"Zoledronic Acid Injection 4 mg\/ 5 mL (0.8 mg\/mL) Single-Dose Viial 5 mL (RX)","description":"\u003cp\u003eZoledronic Acid Injection is used to treat various bone-related conditions. It is commonly prescribed to manage osteoporosis in postmenopausal women and men, reducing the risk of fractures. It also treats Paget's disease of bone and lowers high blood calcium levels (hypercalcemia) associated with cancer. As a bisphosphonate, zoledronic acid works by inhibiting bone resorption, thus strengthening bones and decreasing bone pain. It is typically administered intravenously by healthcare professionals, ensuring appropriate dosage and patient monitoring.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSpecifications: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient\u003c\/strong\u003e: Zoledronic Acid\u003cbr\u003e\u003cstrong\u003eConcentration\u003c\/strong\u003e: 0.8 mg\/mL\u003cbr\u003e\u003cstrong\u003eVolume:\u003c\/strong\u003e 5 mL per vial\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e Single-dose vial\u003cbr\u003e\u003cstrong\u003eBrand:\u003c\/strong\u003e Avet Pharmaceuticals\u003cbr\u003e\u003cstrong\u003eDosage Form: \u003c\/strong\u003eIntravenous injection\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eConcentration and Formulation:\u003c\/strong\u003e Each vial contains 4 mg of zoledronic acid in a 5 mL solution (0.8 mg\/mL).\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e Single-dose vial provides exact dosage for individual treatments.\u003cbr\u003e\u003cstrong\u003eApplications:\u003c\/strong\u003e Effective in treating osteoporosis, Paget's disease of bone, and managing hypercalcemia due to cancer.\u003cbr\u003e\u003cstrong\u003eQuality and Efficacy:\u003c\/strong\u003e Known for its therapeutic reliability, manufactured under strict quality control criteria.\u003cbr\u003e\u003cstrong\u003eAdministration:\u003c\/strong\u003e Designed for intravenous infusion under the supervision of a qualified healthcare provider.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eZoledronic acid is a bisphosphonate, a class of drugs that inhibit osteoclast-mediated bone resorption. By binding to bone mineral, zoledronic acid disrupts the osteoclast activity, leading to decreased bone breakdown and turnover. The net effect is an increase in bone mineral density, reducing the risk of fractures in osteoporosis and slowing the progression of bone damage in other related conditions. Additionally, by lowering serum calcium levels, it effectively treats hypercalcemia associated with malignancy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Preparation:\u003c\/strong\u003e Ensure that the patient is well-hydrated before administering the drug to minimize the risk of renal adverse effects.\u003cbr\u003e\u003cstrong\u003e2. Dosage and Administration:\u003c\/strong\u003e Administer as an intravenous infusion over no less than 15 minutes. Follow specific dosing instructions based on the condition being treated and the patient's health status.\u003cbr\u003e\u003cstrong\u003e3. Monitoring:\u003c\/strong\u003e Regularly check renal function and serum calcium levels pre-and post-administration to ensure patient safety and drug efficacy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal Cautions:\u003c\/strong\u003e Use with caution in patients with compromised renal function. Dose adjustment may be necessary.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypocalcemia:\u003c\/strong\u003e Ensure proper calcium and vitamin D supplementation prior to administration to reduce the risk of hypocalcemia.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity Reactions:\u003c\/strong\u003e Discontinue immediately if signs of allergic reactions or severe skin reactions occur.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Lactation:\u003c\/strong\u003e Not recommended for pregnant or lactating women unless clearly needed and prescribed by a healthcare professional.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eWhile the medication is generally well-tolerated, some patients may experience side effects, including:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e Fever, fatigue, musculoskeletal pain, and flu-like symptoms.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious Side Effects: \u003c\/strong\u003eRenal impairment, acute phase reactions, hypocalcemia, and in rare cases, osteonecrosis of the jaw.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring Required:\u003c\/strong\u003e Close observation for any adverse effects, particularly in individuals with pre-existing conditions that affect renal or bone health.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eZoledronic Acid Injection 4 mg\/5 mL by [Manufacturer Name] represents a crucial intervention for managing bone-catastrophic conditions, ensuring that patients receive informed, safe, and effective treatment aimed at preserving bone integrity and overall physical health. Always consult and adhere to healthcare professional guidance when administering this medication.\u003c\/p\u003e","brand":"Avet Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40388509368392,"sku":"23155-0170-31","price":43.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Zoledronic-Acid-Injection-4-mg-by-Avet-Pharmaceuticals_038bd6a0-5d1d-4f67-a402-cd13e35395cc.jpg?v=1731424616"},{"product_id":"zoledronic-acid-injection-mannitol-water-5-mg-per-100-ml-0-05-mg-per-ml-sterile-solution-single-dose-bottle-100-ml-rx","title":"Zoledronic Acid Injection Mannitol-Water 5 mg Per 100 mL (0.05 mg per mL) Sterile Solution Single-Dose Bottle 100 mL (RX)","description":"\u003cp\u003eZoledronic Acid Injection with Mannitol and Water is a sterile solution available in a single-dose bottle containing 5 mg of zoledronic acid per 100 mL, which equates to 0.05 mg per mL. This formulation is used as a bone resorption inhibitor, primarily indicated for the treatment and prevention of osteoporosis, management of Paget's disease of bone, and to reduce the risk of fractures in certain types of cancer that affect the bones. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKey components include:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eZoledronic Acid (5 mg per 100 mL):\u003c\/strong\u003e A bisphosphonate that inhibits osteoclast-mediated bone resorption, strengthening bones and reducing fracture risk.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMannitol:\u003c\/strong\u003e Often used as a stabilizer in the solution.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWater for Injection:\u003c\/strong\u003e The solvent in which the active drug and other ingredients are dissolved.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis medication is administered intravenously and must be used under the guidance of a healthcare professional, with careful monitoring for potential side effects such as renal impairment, electrolyte imbalance, and rare but serious conditions like osteonecrosis of the jaw.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOsteoporosis: \u003c\/strong\u003eHelps to increase bone mineral density and reduce fractures in postmenopausal women and men.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePaget's Disease of Bone\u003c\/strong\u003e: Normalizes abnormal bone turnover, promoting healthier bone formation.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone Metastases\u003c\/strong\u003e: Reduces the risk of skeletal-related events such as fractures in cancer patients with metastatic bone disease.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eAdministration and Usage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eZoledronic Acid Injection should be administered intravenously by a healthcare professional. The infusion time typically lasts for at least 15 minutes. Proper pre-infusion hydration is recommended, and kidney function and serum calcium levels should be monitored before and after administration to minimize the risk of adverse effects such as renal impairment and hypocalcemia.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore the bottle at controlled room temperature, away from direct sunlight and moisture. Do not freeze. Ensure the product is used before its expiration date.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings and Precautions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMonitor renal function and ensure patients are adequately hydrated prior to administration.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eCheck serum calcium levels before and after infusion.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eBe cautious of potential side effects, including renal impairment, hypocalcemia, and rare conditions such as osteonecrosis of the jaw.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eUse with caution in patients with preexisting renal conditions or electrolyte imbalances.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eZoledronic Acid Injection by Meitheal Pharmaceuticals represents a critical therapeutic option for effectively managing severe bone conditions, contributing to improved patient quality of life through enhanced bone health and reduced risk of fractures.\u003c\/p\u003e","brand":"Meitheal Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40388512284744,"sku":"71288-0806-51","price":109.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Zoledronic-Acid-Injection-Mannitol-Water-5-mg-Vial.jpg?v=1725891554"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/collections\/Bone_Resorption_Inhibitors.jpg?v=1725890936","url":"https:\/\/www.mountainside-medical.com\/collections\/bone-resorption-inhibitors\/avet-pharmaceuticals+bone-loss.oembed","provider":"Mountainside Medical","version":"1.0","type":"link"}